![Quiver Logo](/static/img/logo-icon.png)
![RLYB logo](https://quiver-logos.s3.us-east-2.amazonaws.com/rlyb.png)
Rallybio Corporation Common Stock
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RLYB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of RLYB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RLYB's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to RLYB
Recent picks made for RLYB stock on CNBC
ETFs with the largest estimated holdings in RLYB
Flights by private jets registered to RLYB
![Quiver Logo](/static/img/logo-icon.png)